Cargando…

Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma

PURPOSE: To evaluate the effectiveness and safety of a modified approach using the Ex-PRESS(®) implant combined with a scleral pocket in the management of secondary open-angle glaucoma in hereditary transthyretin amyloidosis (hATTR) at our department. METHODS: This was a retrospective analysis. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Rita, Marta, Ana, Ferreira, André, Figueiredo, Ana, Reis, Rita Falcão, Sampaio, Isabel, Menéres, Maria João
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899011/
https://www.ncbi.nlm.nih.gov/pubmed/36748048
http://dx.doi.org/10.2147/OPTH.S394360
_version_ 1784882552625954816
author Vieira, Rita
Marta, Ana
Ferreira, André
Figueiredo, Ana
Reis, Rita Falcão
Sampaio, Isabel
Menéres, Maria João
author_facet Vieira, Rita
Marta, Ana
Ferreira, André
Figueiredo, Ana
Reis, Rita Falcão
Sampaio, Isabel
Menéres, Maria João
author_sort Vieira, Rita
collection PubMed
description PURPOSE: To evaluate the effectiveness and safety of a modified approach using the Ex-PRESS(®) implant combined with a scleral pocket in the management of secondary open-angle glaucoma in hereditary transthyretin amyloidosis (hATTR) at our department. METHODS: This was a retrospective analysis. The primary endpoints included Intraocular pressure (IOP) evaluation (baseline, 1st day, 1st week, 1, 3, 6, 12 months and at last follow-up) and number of hypotensive drugs (baseline, 6th, 12th months and at last follow-up). As secondary endpoints surgical complications, the need for additional glaucoma surgery and LogMAR BCVA were evaluated. Qualified and complete success were defined as ≥ 30% IOP decrease from baseline, with or without additional medications, respectively. The minimum follow-up was 12 months. RESULTS: A total of 32 eyes were included with a mean follow-up of 2.4±2.9 years. IOP decreased significantly from baseline (27.4±4.4 mmHg) to 1st day (5.00±2.9 mmHg), 1st week (6.9±4.1 mmHg), 1st month (11.7±7.8 mmHg), 3rd month (11.6±6.1 mmHg), 6th month (13.1±6.8 mmHg), 12th month (12.0±3.5 mmHg) and last visit (11.8±2.4 mmHg), p<0.001. There was also a significant reduction in the number of antiglaucoma medications from baseline (3.8±0.6) and last follow-up (0.4±0.8), p<0.001. LogMAR BCVA remained stable (0.25±0.26 at baseline and 0.25±0.24 at last follow-up), p=0.767. Transient hypotony occurred in 17 eyes (53.1%), but only 11 (34.4%) exhibited anterior chamber shallowing and needed additional care, namely cycloplegic drops and viscoelastic injection. Complete surgical success was achieved in 22 eyes (68.8%) and qualified success in 6 eyes (18.8%). Four eyes (12.5%) needed additional glaucoma surgery. CONCLUSION: The modified ExPRESS(®) technique appears to be effective, especially when low levels of IOP are required. Additionally, fewer anti-glaucoma drugs were necessary. In the other hand, hypotony was a common side effect with this procedure, although all patients were properly handled, preserving the surgical outcomes.
format Online
Article
Text
id pubmed-9899011
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98990112023-02-05 Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma Vieira, Rita Marta, Ana Ferreira, André Figueiredo, Ana Reis, Rita Falcão Sampaio, Isabel Menéres, Maria João Clin Ophthalmol Original Research PURPOSE: To evaluate the effectiveness and safety of a modified approach using the Ex-PRESS(®) implant combined with a scleral pocket in the management of secondary open-angle glaucoma in hereditary transthyretin amyloidosis (hATTR) at our department. METHODS: This was a retrospective analysis. The primary endpoints included Intraocular pressure (IOP) evaluation (baseline, 1st day, 1st week, 1, 3, 6, 12 months and at last follow-up) and number of hypotensive drugs (baseline, 6th, 12th months and at last follow-up). As secondary endpoints surgical complications, the need for additional glaucoma surgery and LogMAR BCVA were evaluated. Qualified and complete success were defined as ≥ 30% IOP decrease from baseline, with or without additional medications, respectively. The minimum follow-up was 12 months. RESULTS: A total of 32 eyes were included with a mean follow-up of 2.4±2.9 years. IOP decreased significantly from baseline (27.4±4.4 mmHg) to 1st day (5.00±2.9 mmHg), 1st week (6.9±4.1 mmHg), 1st month (11.7±7.8 mmHg), 3rd month (11.6±6.1 mmHg), 6th month (13.1±6.8 mmHg), 12th month (12.0±3.5 mmHg) and last visit (11.8±2.4 mmHg), p<0.001. There was also a significant reduction in the number of antiglaucoma medications from baseline (3.8±0.6) and last follow-up (0.4±0.8), p<0.001. LogMAR BCVA remained stable (0.25±0.26 at baseline and 0.25±0.24 at last follow-up), p=0.767. Transient hypotony occurred in 17 eyes (53.1%), but only 11 (34.4%) exhibited anterior chamber shallowing and needed additional care, namely cycloplegic drops and viscoelastic injection. Complete surgical success was achieved in 22 eyes (68.8%) and qualified success in 6 eyes (18.8%). Four eyes (12.5%) needed additional glaucoma surgery. CONCLUSION: The modified ExPRESS(®) technique appears to be effective, especially when low levels of IOP are required. Additionally, fewer anti-glaucoma drugs were necessary. In the other hand, hypotony was a common side effect with this procedure, although all patients were properly handled, preserving the surgical outcomes. Dove 2023-01-31 /pmc/articles/PMC9899011/ /pubmed/36748048 http://dx.doi.org/10.2147/OPTH.S394360 Text en © 2023 Vieira et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Vieira, Rita
Marta, Ana
Ferreira, André
Figueiredo, Ana
Reis, Rita Falcão
Sampaio, Isabel
Menéres, Maria João
Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
title Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
title_full Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
title_fullStr Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
title_full_unstemmed Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
title_short Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
title_sort modified technique of ex-press(®) filtration device combined with a scleral pocket for hereditary transthyretin amyloidosis (hattr) secondary open-angle glaucoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899011/
https://www.ncbi.nlm.nih.gov/pubmed/36748048
http://dx.doi.org/10.2147/OPTH.S394360
work_keys_str_mv AT vieirarita modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma
AT martaana modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma
AT ferreiraandre modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma
AT figueiredoana modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma
AT reisritafalcao modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma
AT sampaioisabel modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma
AT meneresmariajoao modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma